Screening & Detection

Real-time polymerase chain reaction (PCR, real-time PCR, or qPCR) enables the detection of bacteria or viruses on the molecular level, with higher degrees of accuracy than microscopy (peering through a microscope to see if certain microorganisms are present) and considerably faster than the days or weeks it takes to grow a culture to determine if someone has a disease. Such inaccuracies and delays can mean the difference between life and death.

The unique, proprietary structure of our CoPrimers creates reactions that are far more specific than competing PCR technologies, to better identify and distinguish between viruses and other pathogens, and are sensitive enough to detect the presence of a single virus in a sample.

The technology also virtually eliminates “primer-dimers” which are the source for false positive test results. This is facilitated by our proprietary CoPrimers Design software. This software uses advanced mathematics developed by our founder, Dr. Brent Satterfield, to facilitate a dramatically shortened development cycle. It is able to quickly and accurately screen millions of possible regions within a genome or a specific gene to determine the ideal CoPrimer pair hybridization sites.

The CoPrimer technology was originally developed specifically to address the need for high-quality AND affordable infectious disease diagnostics in the under-served populations of the world. The reduction in primer-dimers combined with the abbreviated development time results in lower overhead costs while developing higher-quality tests, allowing our infectious disease products to be sold affordably all across the globe.

More information about available infectious disease diagnostics can be found under our Products tab.

Learn more about our Joint Venture initiative to address infectious diseases in India